1. Home
  2. ATAI vs CTEV Comparison

ATAI vs CTEV Comparison

Compare ATAI & CTEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • CTEV
  • Stock Information
  • Founded
  • ATAI 2018
  • CTEV 1980
  • Country
  • ATAI Germany
  • CTEV United States
  • Employees
  • ATAI N/A
  • CTEV N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • CTEV
  • Sector
  • ATAI Health Care
  • CTEV
  • Exchange
  • ATAI Nasdaq
  • CTEV NYSE
  • Market Cap
  • ATAI 271.6M
  • CTEV 295.8M
  • IPO Year
  • ATAI 2021
  • CTEV N/A
  • Fundamental
  • Price
  • ATAI $1.35
  • CTEV $20.15
  • Analyst Decision
  • ATAI Strong Buy
  • CTEV Hold
  • Analyst Count
  • ATAI 4
  • CTEV 1
  • Target Price
  • ATAI $9.00
  • CTEV $19.00
  • AVG Volume (30 Days)
  • ATAI 2.3M
  • CTEV 153.8K
  • Earning Date
  • ATAI 03-17-2025
  • CTEV 05-07-2025
  • Dividend Yield
  • ATAI N/A
  • CTEV N/A
  • EPS Growth
  • ATAI N/A
  • CTEV N/A
  • EPS
  • ATAI N/A
  • CTEV N/A
  • Revenue
  • ATAI $308,000.00
  • CTEV $930,624,000.00
  • Revenue This Year
  • ATAI $80.07
  • CTEV N/A
  • Revenue Next Year
  • ATAI N/A
  • CTEV N/A
  • P/E Ratio
  • ATAI N/A
  • CTEV N/A
  • Revenue Growth
  • ATAI N/A
  • CTEV N/A
  • 52 Week Low
  • ATAI $0.78
  • CTEV $4.80
  • 52 Week High
  • ATAI $2.85
  • CTEV $37.60
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 37.14
  • CTEV N/A
  • Support Level
  • ATAI $1.37
  • CTEV N/A
  • Resistance Level
  • ATAI $1.52
  • CTEV N/A
  • Average True Range (ATR)
  • ATAI 0.13
  • CTEV 0.00
  • MACD
  • ATAI -0.03
  • CTEV 0.00
  • Stochastic Oscillator
  • ATAI 6.31
  • CTEV 0.00

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

About CTEV CLARITEV CORPORATION

Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.

Share on Social Networks: